Drug Shortage Report for APO-SUCRALFATE - TAB 1G

Last updated on 2023-09-22 History
Report ID 169045
Drug Identification Number 02125250
Brand name APO-SUCRALFATE - TAB 1G
Common or Proper name SUCRALFATE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) SUCRALFATE
Strength(s) 1G
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code A02BX
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-06
Estimated end date 2023-09-22
Actual end date 2023-09-15
Shortage status Resolved
Updated date 2023-09-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-09-09 English Compare
v2 2022-09-09 French Compare
v3 2022-10-07 English Compare
v4 2022-10-07 French Compare
v5 2022-10-24 English Compare
v6 2022-10-24 French Compare
v7 2022-11-11 English Compare
v8 2022-11-11 French Compare
v9 2022-11-20 English Compare
v10 2022-11-20 French Compare
v11 2022-12-16 English Compare
v12 2022-12-16 French Compare
v13 2023-01-20 English Compare
v14 2023-01-20 French Compare
v15 2023-01-26 English Compare
v16 2023-01-26 French Compare
v17 2023-02-23 English Compare
v18 2023-02-23 French Compare
v19 2023-03-02 English Compare
v20 2023-03-02 French Compare

Showing 1 to 20 of 40